Prevalence of Fatigue in Patients With Cancer: A Systematic Review and Meta-Analysis

被引:150
作者
Al Maqbali, Mohammed [1 ]
Admin, Dip [1 ]
Al Sinani, Mohammed [2 ]
Al Naamani, Zakariya [3 ]
Al Badi, Khalid [4 ]
Tanash, Mu'ath Ibrahim [5 ]
机构
[1] Minist Hlth, Belfast, Antrim, Oman
[2] Imperial Coll London, Fac Med, Reprod & Dev Biol Dept Surg & Canc, London, England
[3] Queens Univ, Med Biol Ctr, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland
[4] Al Khawarizmi Int Coll, Abu Dhabi, U Arab Emirates
[5] Hashemite Univ, Fac Nursing, Dept Adult Hlth Nursing, Zarqa, Jordan
关键词
Prevalence; fatigue; cancer; systematic review; meta-analysis; QUALITY-OF-LIFE; LONG-TERM SURVIVORS; CLINICALLY RELEVANT FATIGUE; HODGKINS-DISEASE SURVIVORS; CELL LUNG-CANCER; BREAST-CANCER; PROSTATE-CANCER; COLORECTAL-CANCER; RISK-FACTORS; DISTINCT TRAJECTORIES;
D O I
10.1016/j.jpainsymman.2020.07.037
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. Fatigue is a particularly common and troubling symptom that has a negative impact on quality of life throughout all phases of treatment and stages of the illness among patients with cancer. Objectives. The objective of this meta-analysis is to examine the present status of fatigue prevalence in patients with cancer. Methods. The following databases were searched: PubMed, MEDLINE, EMBASE, PsycINFO, Cochrane Library, from inception up to February 2020. Prevalence rates were pooled with meta-analysis using a random-effects model. Heterogeneity was tested using I-squared (I-2) statistics. Results. A total of 129 studies (N = 71,568) published between 1993 and 2020 met the inclusion criteria. The overall prevalence of fatigue was 49% (34,947 of 71,656 participants, 95% CI = 45-53) with significant heterogeneity between studies (P < 0.000; tau(2) = 0.0000; I-2 = 98.88%). Subgroup analyses show that the prevalence of fatigue related to type of cancer ranged from 26.2% in patients with gynecological cancer to 56.3% in studies that included mixed types of cancer. In advanced cancer stage patients, the highest prevalence of fatigue (60.6%) was reported. Fatigue prevalence rates were 62% during treatment and 51% during mixed treatment status. The prevalence of fatigue decreased from 64% in studies published from 1996 to 2000 to 43% in studies published from 2016 to 2020. Metaregression identified female gender as a significant moderator for higher prevalence of fatigue, whereas mean age is not associated with fatigue. Conclusion. This meta-analysis highlights the importance of developing optimal monitoring strategies to reduce fatigue and improve the quality of life of patients with cancer. (C) 2020 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:167 / +
页数:37
相关论文
共 168 条
[1]   Severe fatigue after treatment of ductal carcinoma in situ: A comparison with age-matched breast cancer survivors and healthy controls [J].
Abrahams, H. J. G. ;
Smits, L. ;
De Lugt, M. ;
de Roos, W. K. ;
Kamm, Y. ;
Heins, M. J. ;
Verhagen, A. H. H. V. M. ;
Gielissen, M. F. M. ;
Knoop, H. .
BREAST, 2017, 31 :76-81
[2]   Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors [J].
Abrahams, H. J. G. ;
Gielissen, M. F. M. ;
Schmits, I. C. ;
Verhagen, C. A. H. H. V. M. ;
Rovers, M. M. ;
Knoop, H. .
ANNALS OF ONCOLOGY, 2016, 27 (06) :965-974
[3]  
Al Maqbali M, 2020, CANC NURS, DOI [10.1097/NCC, DOI 10.1097/NCC]
[4]   Quality assessment criteria: psychometric properties of measurement tools for cancer related fatigue [J].
Al Maqbali, Mohammed ;
Hughes, Ciara ;
Gracey, Jackie ;
Rankin, Jane ;
Dunwoody, Lynn ;
Hacker, Eileen .
ACTA ONCOLOGICA, 2019, :1286-1297
[5]   An Exploratory Study of Fatigue and Physical Activity in Canadian Thyroid Cancer Patients [J].
Alhashemi, Ahmad ;
Jones, Jennifer M. ;
Goldstein, David P. ;
Mina, Daniel Santa ;
Thabane, Lehana ;
Sabiston, Catherine M. ;
Chang, Eugene K. ;
Brierley, James D. ;
Sawka, Anna M. .
THYROID, 2017, 27 (09) :1156-1163
[6]   Prevalence, Predictors, and Characteristics of Off-Treatment Fatigue in Breast Cancer Survivors [J].
Andrykowski, Michael A. ;
Donovan, Kristine A. ;
Laronga, Christine ;
Jacobsen, Paul B. .
CANCER, 2010, 116 (24) :5740-5748
[7]   ASCPRO Recommendations for the Assessment of Fatigue as an Outcome in Clinical Trials [J].
Barsevick, Andrea M. ;
Cleeland, Charles S. ;
Manning, Donald C. ;
O'Mara, Ann M. ;
Reeve, Bryce B. ;
Scott, Jane A. ;
Sloan, Jeff A. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (06) :1086-1099
[8]  
Berger A M, 1998, Oncol Nurs Forum, V25, P51
[9]  
Berger AM, 2019, NCCN CLIN PRACTICE G
[10]   Screening, evaluation, and management of cancer-related fatigue: Ready for implementation to practice? [J].
Berger, Ann M. ;
Mitchell, Sandra A. ;
Jacobsen, Paul B. ;
Pirl, William F. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2015, 65 (03) :190-211